Hepatitis B reactivation in patients receiving targeted therapies.

about

RFX1 participates in doxorubicin-induced hepatitis B virus reactivation.

P2860

Q52618967-51D4D406-3276-42C5-9457-8C727C56DE53

P2860

Hepatitis B reactivation in patients receiving targeted therapies.

Item

http://www.wikidata.org/entity/Q39293427

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Hepatitis B reactivation in patients receiving targeted therapies.

@en

Hepatitis B reactivation in patients receiving targeted therapies.

@nl

type

Item

label

Hepatitis B reactivation in patients receiving targeted therapies.

@en

Hepatitis B reactivation in patients receiving targeted therapies.

@nl

prefLabel

Hepatitis B reactivation in patients receiving targeted therapies.

@en

Hepatitis B reactivation in patients receiving targeted therapies.

@nl

P1476

Hepatitis B reactivation in patients receiving targeted therapies.

@en

P2093

Cheng-Shyong Chang

http://www.w3.org/2001/XMLSchema#string

Chien-Yu Tsai

http://www.w3.org/2001/XMLSchema#string

Sheng-Lei Yan

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Chronic hepatitis B: update 2009

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease.

Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma.

Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients.

The difficulties of managing severe hepatitis B virus reactivation.

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10245332.2017.1321882

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28485688

http://www.w3.org/2001/XMLSchema#string

Hepatitis B reactivation in patients receiving targeted therapies.

about

P2860

P2860

Hepatitis B reactivation in patients receiving targeted therapies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698